Director/PDMR Shareholding
RNS Number : 9236A
3i Group PLC
04 June 2021
 

Market Abuse Regulation

 

MAR Article 19

 

Restricted Share Awards

 

Pursuant to the rules of The 3i Group Deferred Bonus Plan 2020, on 4 June 2021 the following individuals, being Directors / persons discharging managerial responsibilities ("PDMR"s) of 3i Group plc (the "Company"), were granted awards over ordinary shares of 73 19/22p each ("Shares") (ISIN: GB00B1YW4409) in the Company as detailed against their names below:

 

PDMR

Number of Shares

S A Borrows

115,174

K J Dunn

49,902

P J White

262,930

J S Wilson

52,965

 

In addition, pursuant to the rules of The 3i Group Deferred Bonus Plan 2020, on 4 June 2021, the following PDMRs of the Company were granted cash settled awards (under which a bonus is paid by reference to a number of notional Shares in the Company) as detailed against their names below:

 

PDMR

Number of Notional Shares

R Collins

26,924

P De Jong

41,676

P Wirtz

41,676

 

Performance Share Awards

 

Pursuant to the rules of The 3i Group Discretionary Share Plan 2020, on 4 June 2021 the following individual, being a PDMR of the Company, was granted an award over Shares (ISIN: GB00B1YW4409) in the Company as detailed against their name below:

 

PDMR

Number of Shares

K J Dunn

15,659

 

Pursuant to the rules of the 3i Group Special Share Award Plan, on 4 June 2021 the following PDMR of the Company, was granted awards over Shares (ISIN: GB00B1YW4409) the Company as detailed against their name below:

 

PDMR

Number of Shares

Phil White

23,830

 

The Performance Share Awards are subject to performance conditions.

 

The consideration for the grant of each of the awards detailed above was nil. The place of the transactions detailed above was London.

 

Each of the Directors/PDMRs above notified the Company of the changes in their interests on 4 June 2021.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUPUPWQUPGGWC